SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 227 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.34 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,592 | -45.1% | 94 | -40.1% | 0.00% | – |
Q2 2023 | $4,719 | +110.1% | 157 | +153.2% | 0.00% | – |
Q1 2023 | $2,246 | +1.5% | 62 | 0.0% | 0.00% | – |
Q4 2022 | $2,212 | +121.2% | 62 | +129.6% | 0.00% | – |
Q3 2022 | $1,000 | 0.0% | 27 | 0.0% | 0.00% | – |
Q2 2022 | $1,000 | -88.9% | 27 | -90.0% | 0.00% | – |
Q1 2022 | $9,000 | +12.5% | 271 | -2.2% | 0.00% | – |
Q4 2021 | $8,000 | +300.0% | 277 | +274.3% | 0.00% | – |
Q3 2021 | $2,000 | -60.0% | 74 | -61.1% | 0.00% | – |
Q4 2020 | $5,000 | +150.0% | 190 | +69.6% | 0.00% | – |
Q1 2020 | $2,000 | -33.3% | 112 | 0.0% | 0.00% | – |
Q4 2019 | $3,000 | -99.5% | 112 | -99.0% | 0.00% | -100.0% |
Q2 2018 | $643,000 | +4.4% | 10,738 | -20.1% | 0.00% | 0.0% |
Q1 2018 | $616,000 | +2.3% | 13,439 | -11.0% | 0.00% | 0.0% |
Q4 2017 | $602,000 | +30.0% | 15,107 | +30.4% | 0.00% | +33.3% |
Q3 2017 | $463,000 | -30.7% | 11,586 | -25.3% | 0.00% | -40.0% |
Q2 2017 | $668,000 | +5.9% | 15,510 | -23.0% | 0.01% | 0.0% |
Q1 2017 | $631,000 | +10.3% | 20,148 | -11.0% | 0.01% | 0.0% |
Q4 2016 | $572,000 | -16.7% | 22,650 | -18.5% | 0.01% | -16.7% |
Q3 2016 | $687,000 | -0.7% | 27,786 | -18.2% | 0.01% | 0.0% |
Q2 2016 | $692,000 | +34500.0% | 33,975 | +32257.1% | 0.01% | – |
Q1 2016 | $2,000 | +100.0% | 105 | +10.5% | 0.00% | – |
Q4 2015 | $1,000 | 0.0% | 95 | +2.2% | 0.00% | – |
Q3 2015 | $1,000 | 0.0% | 93 | +78.8% | 0.00% | – |
Q2 2015 | $1,000 | – | 52 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ASHFORD CAPITAL MANAGEMENT INC | 921,962 | $33,402,683 | 5.00% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 423,500 | $15,326,465 | 4.28% |
ARMISTICE CAPITAL, LLC | 4,350,000 | $157,600,500 | 2.27% |
S&T BANK/PA | 223,775 | $8,107 | 1.46% |
Aristotle Capital Boston, LLC | 1,155,149 | $41,851,071 | 1.29% |
Tributary Capital Management, LLC | 353,671 | $12,813,500 | 1.19% |
Bridge City Capital, LLC | 62,790 | $2,274,882 | 1.14% |
RICE HALL JAMES & ASSOCIATES, LLC | 551,285 | $19,973,056 | 1.14% |
Intrinsic Edge Capital Management LLC | 289,704 | $10,495,976 | 1.05% |
Parkman Healthcare Partners LLC | 131,878 | $4,777,940 | 1.04% |